biologic

(redirected from biologic response modifiers)
Also found in: Dictionary, Thesaurus.

biological

 [bi″o-loj´ĭ-k'l]
1. pertaining to biology.
2. a medicinal preparation made from living organisms and their products, such as a serum or vaccine.
biological clock the physiologic mechanism that governs the rhythmic occurrence of certain biochemical, physiologic, and behavioral phenomena in living organisms. See also biological rhythms.

bi·o·log·ic

, biological (bī'ō-loj'ik, -loj'i-kăl),
Relating to biology.

biologic

(bī′ə-lŏj′ĭk)
n.
A preparation that is synthesized from living organisms or their products, especially a human or animal protein, such as a hormone or antitoxin, that is used as a diagnostic, preventive, or therapeutic agent. Also called biological drug.
adj.
Variant of biological.

biologic

adjective Referring to biology; biological.
 
noun Any therapeutic serum, toxin, anti-toxin or analogous microbial product applicable to the prevention, treatment or cure of diseases or injuries; a bioengineered therapeutic agent—e.g., a hormone, antibody, cytokine—produced in bacteria, animals and other organisms.

bi·o·log·ic

, biological (bī'ŏ-loj'ik, -i-kăl)
Relating to biology.

bi·o·log·ic

, biological (bī'ŏ-loj'ik, -i-kăl)
Relating to biology.

biologic,

adj pertaining to biology.
biologic death,
n the permanent cessation of electrical activity in the central nervous system. Also called brain death.
biologic factors,
n the variables that influence life and living tissues.
biologic (permucosal) seal,
n the health-protecting zone between the living soft tissue and the post or implant in patients with full replacement dental work. Works to prevent bacteria and any other health-threatening organisms from breaching healthy tissue.
biologic science,
n the science that deals with life processes.
biologic value (BV),
n a number reached by comparing the amount of nitrogen retained with the amount absorbed to aid in determining protein quality.
biologic vector,
n the live carrier, usually an arthropod, in which an infectious organism matures prior to infecting a receiver.

biologic


biologic response modifiers
therapeutic agents used to increase or optimize immune responses. Includes immunomodulators, immunoaugmentators, immunoadjuvants, immunostimulators and immunopotentiators.
References in periodicals archive ?
If you are taking a biologic response modifier and have an infection severe enough to require antibiotics, the biologic should not be given until the infection is gone.
Biologic response modifiers are able to trigger the immune system to indirectly affect tumours by increasing cytokines such as interferons and interleukins.
Biologic response modifiers may cause flu like symptoms including fever, chills, nausea and appetite loss.
Patients in the Mid-Atlantic, south Atlantic, and east south central states also were significantly less likely to be treated with an adjuvant biologic response modifier (odds ratios 0.
Lange said the database did not distinguish interferon use from other immune therapies in the biologic response modifier category.
Tocilizumab (Actemra) is a biologic response modifier that inhibits interleukin-6.
Abatacept (Orencia) is another biologic response modifier used in the treatment of RA.
1-3) The discovery and development of targeted biologic response modifiers (BRMs), particularly TNF antagonists, for the treatment of RA has dramatically changed the treatment paradigm and clinical outcomes for RA patients.
Of the respondents, 300 were taking a biologic response modifier (BRM) and 200 were taking a disease-modifying antirheumatic drug (DMARD).
Utilizing the Company's proprietary technology, Trionic Enhanced Biologic Response Modifiers, the Company's products have exceptional effectiveness against a broad spectrum of microorganisms, as well as direct anti-inflammatory activity that block leukotriene, prostaglandin, and cytokine production.
The first in a new class of rheumatoid arthritis (RA) drugs known as biologic response modifiers, ENBREL is an entirely new approach to the management of rheumatoid arthritis.
ATLANTA -- A review of more than 60,000 melanoma patients found that they were more likely to have a sentinel node biopsy and receive adjuvant therapy with a biologic response modifier if they had commercial insurance and were treated at a teaching hospital in a geographic area where these options were more often used.